Comparison of the efficacy and safety of two combined misoprostol regimens for second trimester medical abortion.

Ioannis KalogiannidisIoannis TsakiridisThemistoklis DagklisGeorgios KapetaniosApostolos MamopoulosApostolos Athanasiadis

Published in: The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception (2020)

The administration of vaginal-sublingual misoprostol, when compared with the vaginal-oral regimen, was associated with a shorter induction-to-abortion interval but a higher incidence of severe pain and shivering.

Keyphrases

chronic pain
pain management
risk factors
neuropathic pain
preterm birth
early onset
gestational age
allergic rhinitis
pregnant women
spinal cord injury
postoperative pain